30
Participants
Start Date
November 1, 2023
Primary Completion Date
October 31, 2026
Study Completion Date
December 31, 2026
Quantum Molecular Resonance (QMR) Treatment
Quantum Molecular Resonance (QMR) treatment will be administered using the Rexon-Eye® device (Resono Ophthalmic, Sandrigo, Italy) according to the protocol recommended by the manufacturer. The device features a contact electrode embedded in a mask worn over the participant's closed eyes, and it delivers stimulation to the epidermis of the closed eyelids, extending up to the lid border with an intensity setting of 4-5 on a scale of 0-10. The treatment is non-invasive and painless.
RECRUITING
Singapore National Eye Centre, Singapore
Singapore Eye Research Institute
OTHER